| SCHEDULE OF RECONCILIATION OF BASIC AND DILUTED COMMON SHARES OUTSTANDING |
The
following tables provide a reconciliation of the data used in the calculation of basic and diluted ordinary shares outstanding for the three-month periods ended March 31, 2026, and March 31, 2025, respectively.
SCHEDULE OF RECONCILIATION OF BASIC AND DILUTED COMMON SHARES OUTSTANDING
| Date | |
Transaction Detail | |
Change in Shares | | |
Three-month period ended March 31, 2026, Weighted Average
Ordinary Shares
Outstanding | |
| January 1, 2026 | |
Beginning Balance | |
| | | |
| 100,787,173 | |
| January 15, 2026 | |
Equity-classified Restricted Stock Issuance | |
| 833 | | |
| 694 | |
| January 30, 2026 | |
Equity-classified Restricted Stock Issuance | |
| 7,332 | | |
| 4,888 | |
| February 25, 2026 | |
Equity-classified Restricted Stock Issuance | |
| 1,666 | | |
| 629 | |
| March 13, 2026 | |
Equity-classified Restricted Stock Issuance | |
| 250 | | |
| 50 | |
| March 13, 2026 | |
Settlement of liability-classified share-based compensation | |
| 50,001 | | |
| 10,001 | |
| March 31, 2026 | |
Ending Balance | |
| | | |
| 100,803,435 | |
| Date | |
Transaction Detail | |
Change in Shares | | |
Three-month period ended March 31, 2025, Weighted Average
Ordinary Shares
Outstanding | |
| January 1, 2025 | |
Beginning Balance | |
| | | |
| 96,045,856 | |
| January 6, 2025 | |
Settlement of liability-classified share-based compensation | |
| 61,353 | | |
| 57,263 | |
| February 17, 2025 | |
Equity-classified Restricted Stock Issuance | |
| 666 | | |
| 311 | |
| February 27, 2025 | |
Equity-classified Restricted Stock Issuance | |
| 1,000 | | |
| 356 | |
| March 17, 2025 | |
Equity-classified Restricted Stock Issuance | |
| 12,430 | | |
| 1,934 | |
| March 18, 2025 | |
Equity-classified Restricted Stock Issuance | |
| 231,661 | | |
| 33,461 | |
| March 31, 2025 | |
Ending Balance | |
| | | |
| 96,139,181 | |
|
| SCHEDULE OF BASIC AND DILUTED EARNINGS PER COMMON SHARE |
The
following tables provide the computation of basic and diluted earnings per share (“EPS”) for the three-month periods
ended March 31, 2026, and March 31, 2025, respectively.
SCHEDULE OF BASIC AND DILUTED EARNINGS PER COMMON SHARE
| | |
For the three-month period ended | |
| | |
March 31, 2026 | | |
March 31, 2025 | |
| | |
Net income to Ordinary Shareholders | | |
Weighted-average ordinary shares outstanding | | |
EPS | | |
Net income to Ordinary Shareholders | | |
Weighted-average ordinary shares outstanding | | |
EPS | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Basic EPS - ordinary shares | |
$ | 23,827 | | |
| 100,803,435 | | |
$ | 0.24 | | |
$ | 10,391 | | |
| 96,139,181 | | |
$ | 0.11 | |
| Restricted stock units | |
| - | | |
| 2,128,115 | | |
| (0.01 | ) | |
| - | | |
| 571,303 | | |
| (0.00 | ) |
| Antidilution sequencing - subtotal | |
| 23,827 | | |
| 102,931,550 | | |
| 0.23 | | |
| 10,391 | | |
| 96,710,484 | | |
| 0.11 | |
| 35,540,380 warrants @ $5.75 per half share | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| Diluted EPS - ordinary shares | |
$ | 23,827 | | |
| 102,931,550 | | |
$ | 0.23 | | |
$ | 10,391 | | |
| 96,710,484 | | |
$ | 0.11 | |
|